Equity Research
MyoKardia Surges by 57% After Bristol-Myers Set to Acquire MYOK for $13 Billion in Cash
MyoKardia to attain $225 per share, a premium of 61% over the biotech stock’s Friday closing price. The biotech company, MyoKardia Inc. (MYKO) is set
